ByteBrief
We're a portrait publication through and through. Turn your phone back and your briefing picks up right where you left it.
(We tried widescreen once. It wasn't us.)
1 story in the last 7 days
The latest autoimmune news, distilled by AI into sharp ~100-word summaries. ByteBrief tracks autoimmune across dozens of tech sources and brings you only what matters, updated hourly. Tap any story for the full brief, or open the original source.

Eli Lilly is acquiring a biotech startup for nearly $3 billion to expand into autoimmune diseases. The deal adds new treatment capabilities to the pharmaceutical company's pipeline. Financial terms beyond the purchase price were not detailed.
Summaries by ByteBrief